Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Andreas Schneider, Reto Jost, Christoph Jordi & Jakob Lange. (2023) Autoinjectors for large-volume subcutaneous drug delivery: a review of current research and future directions. Expert Opinion on Drug Delivery 20:6, pages 815-830.
Read now
Read now
Ronak Patel, Pravin Ghadge, Pravin A. Nair, Manish Kumar & Laxmi Adhikary. (2022) A review of bridging clinical studies between different presentations of biological products approved by the United States Food and Drug Administration (US FDA). Expert Opinion on Biological Therapy 22:10, pages 1293-1310.
Read now
Read now
Ronak Patel, Miten Mehta, Meghana Dahiya & Vinu Jose. (2021) A review of use errors reported in human factor validation studies of biological combination products. Journal of Medical Engineering & Technology 45:7, pages 582-592.
Read now
Read now
Ronak Patel, Miten Mehta, Parag Pipalava, Meghana Dahiya, Inderjeet Singh & Vinu Jose. (2019) Insights into human factor studies conducted for US FDA-approved biological combination products. Expert Opinion on Drug Delivery 16:12, pages 1333-1353.
Read now
Read now
Scott Fettner, Christopher Mela, Florian Wildenhahn, Monica Tavanti, Christine Wells, Wendy Douglass & Navita L. Mallalieu. (2019) Evidence of bioequivalence and positive patient user handling of a tocilizumab autoinjector. Expert Opinion on Drug Delivery 16:5, pages 551-561.
Read now
Read now
Articles from other publishers (20)
Klaus Wuchner, Helen C. Brown, Fabiana Canal, Debora Bonvin, Craig Goldhammer, Henri Hebting, Carine Huon, Sebastian M. Kuhn, Prudvi Raj Mudumala, Karen Neuhold, David Riesop, Jean-Sebastien Steffen & Florian Woelfle. (2024) Industry perspective on a holistic container closure integrity approach to parenteral combination products. European Journal of Pharmaceutics and Biopharmaceutics 194, pages 20-35.
Crossref
Crossref
Joseph Weidman, Ligi Mathews & Kedar Gokhale. (2023) Quartz Crystal Microbalance as a Predictive Tool for Drug-Material of Construction Interactions in Intravenous Protein Drug Administration. Journal of Pharmaceutical Sciences 112:12, pages 3154-3163.
Crossref
Crossref
Krishnan Sampathkumar & Bruce A. Kerwin. (2023) Roadmap for Drug Product Development and Manufacturing of Biologics. Journal of Pharmaceutical Sciences.
Crossref
Crossref
Beate Bittner. (2023) Customer-centric product presentations for monoclonal antibodies. AAPS Open 9:1.
Crossref
Crossref
Laura Valenzuela-Vallejo. 2023. Translational Sports Medicine. Translational Sports Medicine
447
451
.
Enrico Fusaro, Patrick Durez, Johannes Wohlrab, Soohyun Lee, SangWook Yoon & Hubert Marotte. (2022) An update on the adalimumab biosimilar landscape following approval of the first high-concentration biosimilar. Immunotherapy 14:3, pages 235-252.
Crossref
Crossref
Beate Bittner & Johannes Schmidt. 2022. Formulation and Device Lifecycle Management of Biotherapeutics. Formulation and Device Lifecycle Management of Biotherapeutics
85
105
.
Beate Bittner & Johannes Schmidt. 2022. Formulation and Device Lifecycle Management of Biotherapeutics. Formulation and Device Lifecycle Management of Biotherapeutics
175
200
.
Danika Rodrigues, Laura M. Tanenbaum, Renuka Thirumangalathu, Sandeep Somani, Kai Zhang, Vineet Kumar, Ketan Amin & Santosh V. Thakkar. (2021) Product-Specific Impact of Viscosity Modulating Formulation Excipients During Ultra-High Concentration Biotherapeutics Drug Product Development. Journal of Pharmaceutical Sciences 110:3, pages 1077-1082.
Crossref
Crossref
Rahul G. Ingle & Wei-Jie Fang. (2021) Prefilled dual chamber devices (DCDs) – Promising high-quality and convenient drug delivery system. International Journal of Pharmaceutics 597, pages 120314.
Crossref
Crossref
Stefania C. Carrara, Michael Ulitzka, Julius Grzeschik, Henri Kornmann, Björn Hock & Harald Kolmar. (2021) From cell line development to the formulated drug product: The art of manufacturing therapeutic monoclonal antibodies. International Journal of Pharmaceutics 594, pages 120164.
Crossref
Crossref
Natalia Navas, Jesús Hermosilla, Anabel Torrente-López, José Hernández-Jiménez, Jose Cabeza, Raquel Pérez-Robles & Antonio Salmerón-García. (2020) Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes. Journal of Pharmaceutical Analysis 10:6, pages 532-545.
Crossref
Crossref
Dolly A. Parasrampuria, Rajesh Bandekar & Thomas A. Puchalski. (2020) Scientific diligence for oncology drugs: a pharmacology, translational medicine and clinical perspective. Drug Discovery Today 25:10, pages 1855-1864.
Crossref
Crossref
Fran DeGrazio & Diane Paskiet. (2020) Injectable Combination Product Development: Facilitating Risk-Based Assessments for Efficiency and Patient Centric Outcomes. Journal of Pharmaceutical Sciences 109:7, pages 2101-2115.
Crossref
Crossref
Whitney M. Simerlein, Kristin E. Beeker, David B. Cruse & Kristy L. Brittain. (2020) Assistance with injectable medications: Implementation of a pharmacist-run specialty pharmacy injection clinic. Journal of the American Pharmacists Association 60:3, pages S76-S79.
Crossref
Crossref
Ping Hu, Jie Wang, Jeffery Florian, Katherine Shatzer, Alan M. Stevens, Jacqueline Gertz, Ping Ji, Shiew Mei Huang, Issam Zineh & Yow-Ming C. Wang. (2020) Systematic Review of Device Parameters and Design of Studies Bridging Biologic-Device Combination Products Using Prefilled Syringes and Autoinjectors. The AAPS Journal 22:2.
Crossref
Crossref
Prakash Manikwar, Sri Hari Raju Mulagapati, Srinath Kasturirangan, Khashayar Moez, Godfrey Jonah Rainey & Brian Lobo. (2020) Characterization of a Novel Bispecific Antibody With Improved Conformational and Chemical Stability. Journal of Pharmaceutical Sciences 109:1, pages 220-232.
Crossref
Crossref
John K. Towns. 2020. Development of Biopharmaceutical Drug-Device Products. Development of Biopharmaceutical Drug-Device Products
767
790
.
Amita Datta-Mannan. (2019) Mechanisms Influencing the Pharmacokinetics and Disposition of Monoclonal Antibodies and Peptides. Drug Metabolism and Disposition 47:10, pages 1100-1110.
Crossref
Crossref
Arathi Kizhedath, Micael Karlberg & Jarka Glassey. (2019) Cross‐Interaction Chromatography‐Based QSAR Model for Early‐Stage Screening to Facilitate Enhanced Developability of Monoclonal Antibody Therapeutics. Biotechnology Journal 14:8.
Crossref
Crossref